|
 |
Linda
Hengstler,
publisher, editor, and friend, ends 14-year stint at CCJM
Under Ms. Hengstler’s
guidance, the Journal has found and grown into its niche as an
increasingly appreciated and widely read educational publication
for the busy clinician.
J.D. CLOUGH and B.F. MANDELL
|
 |
Halting
the progression of heart failure: Finding the optimal combination
therapy
Recommendations on how to find the optimal combination of agents
that can slow the progression of heart failure while minimizing
side effects.
J.N. BASILE
|
 |
A
primer on referring patients for psychotherapy
With many models of psychotherapy available, finding a good fit
between therapist and patient is crucial.
S.M. BEA and G.E. TESAR
|
 |
A
23-year-old man with a continuous heart murmur
What is the cause of this patient’s cardiac symptoms? A
self-test.
K. MIKIELSKI, J. BRECHTKEN, and H. LEVER
|
 |
Diagnosis
of lupus: A glass half full
The tests will
always be imperfect, but with better knowledge of how they
perform, we can look at the clinical laboratory’s role in lupus
diagnosis as a glass half full rather than half empty.
J.D. CLOUGH
|
|
|
Tired,
aching, ANA-positive: Does your patient have lupus or
fibromyalgia?
Do not rely on
the antinuclear antibody test to make the distinction between
fibromyalgia and lupus.
D.E. BLUMENTHAL
|
 |
 Brief answers to specific clinical
questions |
What
is the best way to diagnose streptococcal pharyngitis?
Rapid tests are highly specific but less sensitive. Throat culture
is still the gold standard.
J. GOLDFARB
|
| |
Advances
in treatment of chronic hepatitis C: ‘Pegylated’ interferons
New formulations
of interferon alfa that incorporate polyethylene glycol in the
drug molecule are an important advance in the treatment of chronic
hepatitis C.
K.A. SHARIEFF, D. DUNCAN, and Z. YOUNOSSI
|
| |
Idiopathic
retroperitoneal fibrosis Prompt diagnosis preserves organ function
The chief dangers
from idiopathic retroperitoneal fibrosis—ureteral obstruction
with loss of renal function, and other organ involvement—are
avoidable and treatable with prompt diagnosis.
S. MONEV
|
| |
Chronic
tension-type headache: Advice for the viselike-headache patient
About 3% of
people complain of daily viselike headaches without associated
symptoms. Therapy consists of tricyclic antidepressants,
biofeedback, and stress management, although solid data are
lacking.
G.D. SOLOMON
|
|
Patient
Information Taking
the tension out of tension
headaces |
Brain natriuretic peptide: A marker of heart failure
